Európska únia - bulharčina - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - анти-туморни агенти - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Európska únia - bulharčina - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - Неоплазми на гърдата - Ендокринна терапия - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Európska únia - bulharčina - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - Лимфом, мантел-клетка - Антинеопластични средства - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 10 mg modified - release tablets

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 30 mg modified - release tablets

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 60 mg modified - release tablets

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 100 mg modified - release tablets

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 120 mg prolonged - release capsules

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

mundipharma gesellschaft m.b.h. - Морфин - 200 mg prolonged - release capsules

Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

ever neuro pharma gmbh - Апоморфина хидрохлорид - 5 mg/ml solution for infusion